Data used in this paper are not owned by authors and are from the Nurses' Health Study and Health Professionals Follow-up Study. Procedures to obtain access to the data are described at the study websites: <http://www.nurseshealthstudy.org/researchers> and <https://www.hsph.harvard.edu/hpfs/>.

Introduction {#sec001}
============

Vitamin D has been associated with decreased risk of several sites of cancers, including colorectal,\[[@pone.0160308.ref001]\] breast,\[[@pone.0160308.ref002], [@pone.0160308.ref003]\] and kidney cancers,\[[@pone.0160308.ref004]\] but its association with risk of skin cancer including melanoma and keratinocyte carcinoma (KC, formerly known as non-melanoma skin cancer), the most prevalent cancer in the United States (US)\[[@pone.0160308.ref005]\], is still unclear. Skin is one of the primary organ for vitamin D synthesis and metabolism.\[[@pone.0160308.ref006]\] Previous experimental studies have shown a protective effect of vitamin D against ultraviolet radiation--induced DNA damage and skin cancer development.\[[@pone.0160308.ref007], [@pone.0160308.ref008]\] Several researchers suggested that orally taken vitamin D could decrease the risk of skin cancer. \[[@pone.0160308.ref009], [@pone.0160308.ref010]\] However, epidemiologic studies on the association between vitamin D and skin cancer development have been limited and showed inconsistent results.\[[@pone.0160308.ref011]--[@pone.0160308.ref013]\] A recent meta-analysis on vitamin D intake and skin cancer found no association between higher vitamin D intake and melanoma and basal cell carcinoma (BCC).\[[@pone.0160308.ref014]\] To our knowledge no data exist on vitamin D intake and squamous cell carcinoma (SCC) risk. Most previous epidemiologic studies had focused on a single measurement of plasma 25(OH)D as a marker of vitamin D level\[[@pone.0160308.ref015]--[@pone.0160308.ref017]\], and a recent meta-analysis found a statistically significant positive association between risk of KC and serum 25(OH)D level.\[[@pone.0160308.ref014]\] As serum 25(OH)D levels may reflect the accumulative storage of bodily vitamin D obtained from different resources\[[@pone.0160308.ref018]\] and the main source of vitamin D is the exposure to sunlight (ultraviolet B; a risk factor for skin cancer) of the skin\[[@pone.0160308.ref019]\], the effect of ultraviolet radiation exposure may have confounded the associations\[[@pone.0160308.ref020]--[@pone.0160308.ref022]\].

In our study, we prospectively examined the association between vitamin D intake including intakes from both diet and supplements and risk of KC (including separate evaluation of SCC) and melanoma based on data from two cohort studies: the Nurses' Health Study (NHS, 1984--2010) and the Health Professionals Follow-up Study (HPFS, 1986--2010).

Methods {#sec002}
=======

Study Population {#sec003}
----------------

Details of the two cohorts have been described elsewhere.\[[@pone.0160308.ref011], [@pone.0160308.ref023], [@pone.0160308.ref024]\] In brief, the NHS was established in 1976, when 121,700 US female registered nurses, aged 30--55 years completed an initial questionnaire regarding their lifestyle and medical history. The HPFS was initiated in 1986 when 51,529 male health professionals aged 40--75 years completed a questionnaire that inquired about medical history and lifestyle practices in 1986. The questionnaire data was updated biennially in both cohorts, with the follow-up rates generally exceeding 90%. The present study was approved by the Institutional Review Boards of Brigham and Women's Hospital and Harvard School of Public Health.

Assessment of Vitamin D intake and other Dietary Consumption {#sec004}
------------------------------------------------------------

To assess dietary intake, we used a food frequency questionnaire (FFQ) to collect dietary information in 1984 in the NHS, and every four years since 1986 in the NHS and HPFS. Participants were asked how often on average they had consumed each type of food during the previous year. Our nutrient database was primarily based on data from the US Department of Agriculture. In addition, information on current use and dose of multivitamins and specific supplements were collected biennially. Total vitamin D intake was calculated by adding together intakes from dietary vitamin D, vitamin D-specific supplements and multivitamins containing vitamin D. In validation studies, dietary intake assessed by using the FFQ has been demonstrated to be a valid estimator of food intake when compared with multiple diet records.\[[@pone.0160308.ref025], [@pone.0160308.ref026]\] The correlation coefficients ranged from 0.62--0.81 in the NHS and 0.58--0.88 in the HPFS between intakes of major dietary sources of vitamin D (skim milk, whole milk, fatty fish, and breakfast cereal) assessed on the FFQ and intakes assessed on two 1-week dietary records.\[[@pone.0160308.ref025], [@pone.0160308.ref026]\] Data on other dietary factors, including intakes of total energy, citrus, alcohol, and coffee consumption, was also collected by the FFQs.

Assessment of Covariates {#sec005}
------------------------

Biennially, we collected information on body weight, physical activity, and smoking history in both women and men and menopausal status and post-menopausal hormone use among women. Height information was collected in 1976 in NHS and in 1986 in HPFS. We also collected major skin cancer associated factors\[[@pone.0160308.ref021], [@pone.0160308.ref027]\], including family history of melanoma; natural hair color; number of moles; skin reaction to sun exposure as a child/adolescent; number of blistering sunburns; average time spent in direct sunlight since high school; and cumulative UV flux at residence since baseline.

Assessment of Basal cell carcinoma (BCC), Squamous cell cancer (SCC), and Melanoma Cases {#sec006}
----------------------------------------------------------------------------------------

Biennially, participants had reported diagnoses of BCC, SCC, or melanoma during the previous 2 years. Participants who reported SCC or melanoma were asked for permission to review their medical and pathological reports. Study physicians reviewed their reports to confirm the diagnoses. As for self-reported cases of BCC, we could not obtain medical records, but previous validation studies in the two cohorts have demonstrated a high accuracy of self-reported BCC, with around 90% confirmed by histopathology records.\[[@pone.0160308.ref012], [@pone.0160308.ref028], [@pone.0160308.ref029]\]

Statistical Analysis {#sec007}
--------------------

We followed participants for incident BCC, SCC and melanoma starting from 1984 in the NHS and 1986 in the HPFS. We excluded participants who had missing data on vitamin D intake at baseline and 49,617 HPFS men and 81,685 NHS women served as the base population. Individuals with a history of any cancer were excluded. Due to small cases of KC and melanoma in non-white participants,\[[@pone.0160308.ref021]\] the analyses were restricted to Caucasians. After exclusions, 63,760 women and 41,530 men remained in the present study.

Person-years of follow-up were calculated from the return month of the baseline survey to the date of the first report of any cancer, date of death, or end of follow-up (June 1, 2010 for women; January 1, 2010 for men), whichever came first.

To better estimate long-term dietary intake and to minimize within-person variation, we used cumulative averages of vitamin D intake derived throughout the entire follow-up period. Energy-adjusted vitamin D intake calculated from regression-residual method was used to minimize the variation due to energy intake and its related measurement error.\[[@pone.0160308.ref030]\] Total and dietary vitamin D intakes were categorized into quintiles with the lowest quintile as a reference. Supplementary vitamin D intakes were categorized as following: none, 1--99, 100--199, 200--399, ≥ 400 IU/d.

Cox proportional hazard models were used to assess the hazard ratios (HR) and 95% confidence intervals (CI) of BCC, SCC and melanoma associated with total, dietary and supplementary vitamin D intake. In multivariate analyses of vitamin D intake, we adjusted for following possible confounders \[[@pone.0160308.ref031], [@pone.0160308.ref032]\] and other skin cancer risk factors \[[@pone.0160308.ref021], [@pone.0160308.ref027]\]: family history of melanoma (yes vs. no), natural hair color (red, blonde, light brown, dark brown, black), number of arm moles (0, 1--2, 3--9, ≥10), sunburn susceptibility as a child/adolescent (none/some redness, burn, painful burn/blisters), number of lifetime blistering sunburns (0, 1--4, 5--9, ≥10), average time spent in direct sunlight since high school (\<2, 2--5, 6--9, ≥10 hrs/wk), cumulative UV flux since baseline (quintiles), body mass index (\<25.0, 25.0--29.9, 30.0--34.9, ≥35.0 kg/m^2^), physical activity (quintiles), smoking status (never, past, current with 1--14, 15--24, or ≥25 cigarettes/d), intakes of total energy (quintiles), alcohol (0, 0.1--4.9, 5.0--9.9, 10.0--19.9, ≥20.0 g/d), coffee (0, \<1, 1--2, ≥3 cup/d) and citrus intake (quintiles). Among women analyses were additionally adjusted for menopausal status and postmenopausal hormone use. Trend tests were conducted by assigning median values for each category and analyzing this value as a continuous variable in the models. We performed separately analyses for the HPFS and the NHS, and then calculated pooled HRs using a random-effects model. P values for heterogeneity were calculated using Q statistics.

We performed several sensitivity analyses. First, we calculated the HRs of KC or melanoma in association with consumption of major vitamin D-rich food items such as fish, dairy, milk (skimmed and whole), breakfast cereal and egg.\[[@pone.0160308.ref025], [@pone.0160308.ref026]\] Second, if the number of skin cancer cases is enough, we further categorized total and dietary vitamin D intakes into deciles. Second, we performed stratified analysis according to major sun exposure variables, including annual UV flux at residence, history of blistering sunburns, and average time spent in direct sunlight since high school. Statistical tests were performed using SAS software version 9.2 (SAS Institute Inc., Cary, North Carolina). All statistical tests were two-sided, and the significance level was set at P less than 0.05.

Results {#sec008}
=======

Age-adjusted characteristics of participants (63,760 women and 41,530 men) according to the vitamin D intake are shown in [Table 1](#pone.0160308.t001){ref-type="table"}. Participants with higher intake of total vitamin D tended to be older and to have higher levels of physical activity and higher proportion of sunscreen use. Both men and women with lower total vitamin D intake were more likely to smoke, and consumed higher amount of alcohol intake.

10.1371/journal.pone.0160308.t001

###### Baseline Characteristics of Study Participants According to Quintile of Total Vitamin D intake in the Nurses' Health Study and Health Professionals Follow-Up Study.

![](pone.0160308.t001){#pone.0160308.t001g}

                                                            Quintile of Total Vitamin D intake                                                      
  --------------------------------------------------------- ------------------------------------ ---------------- ---------------- ---------------- ----------------
  **Women (1984)**                                                                                                                                  
  Number of participants                                    12,582                               12,734           12,779           12,871           12,794
  Age (year)                                                48.9(7.0)                            49.5(7.1)        50.2(7.2)        50.3(7.2)        51.5(7.1)
  Family history of melanoma, %                             6.5                                  6.8              7.1              7.4              7.1
  Red/blonde hair, %                                        15.5                                 15.6             15.4             15.3             16.6
  Painful burn/blisters reaction as a child/adolescent, %   14.1                                 14.3             14.6             14.7             15.6
  No. of blistering sunburns                                8.5(7.0)                             8.7(6.9)         8.7(6.9)         8.9(6.9)         8.8(7.0)
  Use of sunscreen, %                                       20.2                                 22.2             23.9             25.8             28.3
  Annual UV flux at residence (×10^−4^ RB count)            121.8(24.5)                          121.6(24.2)      120.1(23.2)      121.4(24.1)      123.6(25.4)
  Body mass index (kg/m^2^)                                 25.0(4.9)                            25.2(4.8)        25.3(4.8)        25.0(4.7)        24.7(4.6)
  Physical activity level (MET hrs/wk)                      12.3(19.2)                           12.7(18.2)       13.9(20.2)       14.5(19.4)       16.6(23.9)
  Current smoking, %                                        30.1                                 24.5             22.8             22.1             21.1
  Menopause status, %                                       46.2                                 45.8             45.8             46.2             46.8
  Current hormones use in postmenopausal women,^a^ %        20.6                                 21.5             22.9             26.0             30.4
  Total Vit D intake, IU/d                                  92.5(23.1)                           159.0(17.3)      231.0(27.8)      382.0(62.8)      714.5(243.3)
  Dietary Vit D intake, IU/d                                92.6(23.7)                           154.0(23.7)      216.3(42.4)      236.7(110.4)     235.7(124.3)
  Supplemental Vit D intake, IU/d                           0.5(5.2)                             3.0(13.3)        13.3(43.2)       159.7(159.9)     455.6(223.3)
  Total energy intake (kcal/d)                              1644.1(539.9)                        1787.8(513.5)    1806.1(544.5)    1896.6(515.3)    1611.7(473.1)
  Alcohol intake (g/d)                                      8.7(13.7)                            7.4(11.7)        6.3(10.4)        6.8(11.7)        6.3(10.2)
  **Men (1986)**                                                                                                                                    
  Number of participants                                    8,462                                8,353            8,339            8,295            8,081
  Age (year)                                                51.5(9.2)                            52.6(9.5)        53.4(9.7)        53.8(9.7)        55.5(9.6)
  Family history of melanoma, %                             3.5                                  3.9              4.2              4.2              4.3
  Red/blonde hair, %                                        12.9                                 12.8             13.9             13.7             13.3
  Painful burn/blisters reaction as a child/adolescent, %   23.7                                 22.6             23.8             24.6             23.2
  No. of blistering sunburns                                12.8(12.1)                           12.6(12.1)       13.0(12.0)       13.1(12.1)       12.7(12.1)
  Annual UV flux at residence (×10^−4^ RB count)            131.0(27.2)                          128.7(26.5)      128.1(26.4)      128.4(26.9)      129.3(27.3)
  Body mass index (kg/m^2^)                                 25.2(5.2)                            25.2(5.0)        25.1(4.9)        24.8(5.0)        24.7(5.0)
  Physical activity level (MET hrs/wk)                      18.6(30.7)                           20.2(26.9)       21.3(31.3)       21.3(28.1)       24.0(32.1)
  Current smoking, %                                        11.5                                 9.6              9.2              9.2              8.4
  Total Vit D intake, IU/d                                  123.7(36.0)                          214.2(22.7)      309.6(34.6)      489.0(70.0)      907.8(315.4)
  Dietary Vit D intake, IU/d                                122.6(36.9)                          209.3(32.6)      289.2(62.3)      317.5(148.5)     369.9(217.0)
  Supplemental Vit D intake, IU/d                           2.7(12.1)                            7.1(21.5)        23.7(59.7)       174.9(171.3)     493.1(311.0)
  Total energy intake (kcal/d)                              1,929.1(617.6)                       1,997.9(619.0)   2,038.7(627.7)   2,126.1(616.7)   1,855.5(573.4)
  Alcohol intake (g/d)                                      14.0(19.0)                           12.2(16.0)       10.9(14.8)       11.6(16.1)       10.0(13.5)

NOTE: Except for data on age and number of participants, all data are standardized to the age distribution of the study population.

During 24--26 years of follow-up, we documented 20,840 incident BCCs 2,329 incident SCCs and 1,320 melanomas. The medians of total vitamin D intake for extreme quintiles were 124.8 and 638.2 IU/d for women and 156.0 and 775.3 IU/d for men, respectively. Contrary to hypothesis, total vitamin D intake was significantly associated with increased risk of BCC, even after multivariable adjustment ([Table 2](#pone.0160308.t002){ref-type="table"}). The HRs of BCC for the extreme quintiles were 1.12 (95% CI = 1.05 to 1.19; *P*~trend~\<0.01) in women and 1.07 (95% CI = 1.00 to 1.15; *P*~trend~ = 0.14) in men; the pooled HR was 1.10 (95% CI = 1.05 to 1.15; *P*~trend~ = 0.05). The multivariable pooled HRs of BCC for top versus bottom deciles were 1.14 (95% CI = 1.07 to 1.22; *P*~trend~ \<0.01) for total vitamin D intake and 1.16 (95% CI = 1.09 to 1.24; *P*~trend~ \<0.001) for dietary vitamin D intake. Total vitamin D intake was also positively associated with risk of SCC and melanoma in age-adjusted analysis. However, after adjustment for other risk factors, total vitamin D consumption was not significantly associated with the risk of SCC or melanoma.

10.1371/journal.pone.0160308.t002

###### Hazard ratios (and 95% confidence intervals) of keratinocyte carcinoma and melanoma by total vitamin D intake in the Nurses' Health Study (NHS), and Health Professionals Follow-Up Study (HPFS).

![](pone.0160308.t002){#pone.0160308.t002g}

                                                                          Quintile of total vitamin D intake   P for trend                                                                     
  ----------------------------------------------------------------------- ------------------------------------ ------------------- ------------------- ------------------- ------------------- ----------
  **Basal cell carcinoma**                                                                                                                                                                     
  **    NHS**                                                                                                                                                                                  
  **    **Median total vitamin D, IU/d                                    124.8                                210.9               304.5               437.4               638.2               
  **      **No. of cases                                                  1862                                 2245                2530                2677                2493                
  **      **Person-years                                                  249295                               267002              268627              262065              234592              
  **      **Age-adjusted                                                  1 (referent)                         1.08 (1.01, 1.14)   1.18 (1.11, 1.25)   1.26 (1.18, 1.33)   1.27 (1.19, 1.34)   \<0.0001
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.02 (0.95, 1.08)   1.08 (1.02, 1.15)   1.13 (1.06, 1.20)   1.12 (1.05, 1.19)   \<0.0001
  **    HPFS**                                                                                                                                                                                 
  **    **Median total vitamin D, IU/d                                    156.0                                253.5               363.2               519.9               775.3               
  **      **No. of cases                                                  1552                                 1792                1926                1915                1848                
  **      **Person-years                                                  146434                               143684              141854              137579              127496              
  **      **Age-adjusted                                                  1 (referent)                         1.13 (1.05, 1.20)   1.19 (1.12, 1.28)   1.19 (1.12, 1.28)   1.18 (1.11, 1.27)   \<0.0001
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.05 (0.98, 1.13)   1.08 (1.01, 1.16)   1.06 (0.99, 1.14)   1.07 (1.00, 1.15)   0.14
  **    Pooled**[^**†**^](#t002fn002){ref-type="table-fn"}                                                                                                                                     
  **      **Age-adjusted                                                  1 (referent)                         1.10 (1.05, 1.15)   1.19 (1.13, 1.24)   1.23 (1.17, 1.29)   1.23 (1.15, 1.31)   \<0.001
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.03 (0.99, 1.08)   1.08 (1.04, 1.13)   1.10 (1.04, 1.16)   1.10 (1.05, 1.15)   0.05
  **Squamous cell cancer**                                                                                                                                                                     
  **    NHS**                                                                                                                                                                                  
  **      **No. of cases                                                  198                                  254                 273                 222                 245                 
  **      **Person-years                                                  250275                               268142              269897              263488              235873              
  **      **Age-adjusted                                                  1 (referent)                         1.13 (0.94, 1.36)   1.18 (0.98, 1.41)   0.96 (0.79, 1.17)   1.18 (0.97, 1.42)   0.47
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.04 (0.86, 1.25)   1.04 (0.87, 1.26)   0.83 (0.68, 1.01)   1.00 (0.82, 1.21)   0.33
  **    HPFS**                                                                                                                                                                                 
  **      **No. of cases                                                  195                                  234                 264                 210                 234                 
  **      **Person-years                                                  147775                               145240              143482              139252              129070              
  **      **Age-adjusted                                                  1 (referent)                         1.14 (0.94, 1.38)   1.27 (1.05, 1.53)   0.99 (0.82, 1.21)   1.14 (0.94, 1.38)   0.71
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.04 (0.86, 1.25)   1.11 (0.92, 1.34)   0.85 (0.70, 1.04)   1.04 (0.85, 1.26)   0.61
  **    Pooled**[^**†**^](#t002fn002){ref-type="table-fn"}                                                                                                                                     
  **      **Age-adjusted                                                  1 (referent)                         1.13 (0.99, 1.29)   1.22 (1.07, 1.39)   0.98 (0.85, 1.12)   1.16 (1.01, 1.33)   0.45
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.04 (0.91, 1.19)   1.07 (0.94, 1.23)   0.84 (0.73, 0.96)   1.02 (0.89, 1.17)   0.30
  **Melanoma**                                                                                                                                                                                 
  **    NHS**                                                                                                                                                                                  
  **      **No. of cases                                                  114                                  170                 158                 153                 144                 
  **      **Person-years                                                  250335                               268208              269995              263538              235957              
  **      **Age-adjusted                                                  1 (referent)                         1.36 (1.07, 1.73)   1.25 (0.98, 1.59)   1.25 (0.98, 1.59)   1.33 (1.04, 1.71)   0.14
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.24 (0.98, 1.58)   1.10 (0.86, 1.40)   1.09 (0.85, 1.39)   1.15 (0.90, 1.49)   0.74
  **    HPFS**                                                                                                                                                                                 
  **      **No. of cases                                                  105                                  115                 122                 122                 117                 
  **      **Person-years                                                  147859                               145335              143613              139301              129155              
  **      **Age-adjusted                                                  1 (referent)                         1.09 (0.84, 1.42)   1.16 (0.89, 1.50)   1.17 (0.90, 1.52)   1.19 (0.91, 1.55)   0.21
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         0.99 (0.76, 1.30)   1.01 (0.77, 1.31)   0.99 (0.76, 1.29)   1.03 (0.78, 1.35)   0.85
  **    Pooled**[^**†**^](#t002fn002){ref-type="table-fn"}                                                                                                                                     
  **      **Age-adjusted                                                  1 (referent)                         1.23 (0.99, 1.52)   1.21 (1.01, 1.44)   1.21 (1.01, 1.45)   1.27 (1.06, 1.52)   0.05
  **      **Multivariate-adjusted [\*](#t002fn001){ref-type="table-fn"}   1 (referent)                         1.12 (0.90, 1.39)   1.05 (0.88, 1.26)   1.04 (0.87, 1.24)   1.09 (0.91, 1.31)   0.71

\* Adjusted for family history of melanoma, natural hair color, number of arm moles, sunburn susceptibility as a child/adolescent, number of lifetime blistering sunburns, average time spent in direct sunlight since high school, cumulative UV flux since baseline, body mass index, physical activity, smoking status, intakes of total energy, alcohol, coffee and citrus intake. Among women analyses were additionally adjusted for menopausal status and postmenopausal hormone use.

^**†**^ The multivariate-adjusted hazard ratios from each cohort were pooled using random effects model.

Higher intakes of vitamin D from food and from supplements were also each associated with increased risk of BCC. The multivariable pooled HR of BCC for top versus bottom quintiles of dietary vitamin D intake was 1.13 (95% CI = 1.07 to 1.20; *P*~trend~ \<0.01) in a dose-dependent manner ([Table 3](#pone.0160308.t003){ref-type="table"}). Participants who took supplementary vitamin D ≥ 400 IU/d also had a higher risk of BCC (pooled HR = 1.07, 95% CI = 1.03 to 1.12; *P*~trend~ = 0.03) than non-users ([Table 4](#pone.0160308.t004){ref-type="table"}). In a sensitivity analysis adjusting for both dietary vitamin D intake and supplemental vitamin D intake in the model simultaneously, no substantial differences in trends were found. In multivariate analysis, dietary or supplemental vitamin D consumption did not show any protective effects on SCC or melanoma incidence (Tables [3](#pone.0160308.t003){ref-type="table"} and [4](#pone.0160308.t004){ref-type="table"}), while a non-significant increased risk was found with higher intake of vitamin D from food for SCC (pooled HR = 1.14, 95% CI = 0.95 to 1.36; *P*~trend~ = 0.41) and melanoma (pooled HR = 1.06, 95% CI = 0.88 to 1.28; *P*~trend~ = 0.55).

10.1371/journal.pone.0160308.t003

###### Hazard ratios (and 95% confidence intervals) of skin cancer by dietary vitamin D intake in the Nurses' Health Study (NHS), and Health Professionals Follow-Up Study (HPFS).
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                                                                          Quintile of dietary vitamin D intake   P for trend                                                                     
  ----------------------------------------------------------------------- -------------------------------------- ------------------- ------------------- ------------------- ------------------- ----------
  **Basal cell carcinoma**                                                                                                                                                                       
  **    NHS**                                                                                                                                                                                    
  **    **Median dietary vitamin D, IU/d                                  97.6                                   145.0               185.2               233.6               314.4               
  **      **No. of cases                                                  1963                                   2274                2583                2542                2445                
  **      **Person-years                                                  253052                                 264672              265341              259109              239408              
  **      **Age-adjusted                                                  1 (referent)                           1.07 (1.01, 1.14)   1.18 (1.11, 1.25)   1.16 (1.09, 1.23)   1.18 (1.11, 1.25)   \<0.0001
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.03 (0.97, 1.10)   1.13 (1.06, 1.20)   1.11 (1.04, 1.18)   1.13 (1.07, 1.20)   \<0.001
  **    HPFS**                                                                                                                                                                                   
  **    **Median dietary vitamin D, IU/d                                  126.3                                  192.3               245.8               311.0               433.8               
  **      **No. of cases                                                  1619                                   1843                1829                1895                1847                
  **      **Person-years                                                  148149                                 144004              139649              136953              128294              
  **      **Age-adjusted                                                  1 (referent)                           1.13 (1.05, 1.20)   1.13 (1.06, 1.21)   1.17 (1.10, 1.25)   1.16 (1.09, 1.25)   \<0.0001
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.09 (1.02, 1.16)   1.07 (1.00, 1.15)   1.10 (1.03, 1.18)   1.12 (1.04, 1.20)   \<0.01
  **    Pooled**[^**†**^](#t003fn002){ref-type="table-fn"}                                                                                                                                       
  **      **Age-adjusted                                                  1 (referent)                           1.10 (1.04, 1.15)   1.16 (1.11, 1.21)   1.17 (1.12, 1.22)   1.17 (1.12, 1.23)   \<0.0001
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.06 (1.01, 1.11)   1.10 (1.05, 1.16)   1.10 (1.06, 1.15)   1.13 (1.08, 1.18)   \<0.001
  **Squamous cell cancer**                                                                                                                                                                       
  **    NHS**                                                                                                                                                                                    
  **      **No. of cases                                                  173                                    284                 251                 249                 235                 
  **      **Person-years                                                  254082                                 265801              266686              260457              240649              
  **      **Age-adjusted                                                  1 (referent)                           1.51 (1.25, 1.82    1.29 (1.06, 1.56)   1.28 (1.06, 1.56)   1.29 (1.06, 1.57)   0.28
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.45 (1.20, 1.76)   1.23 (1.01, 1.49)   1.23 (1.01, 1.50)   1.25 (1.02, 1.52)   0.43
  **    HPFS**                                                                                                                                                                                   
  **      **No. of cases                                                  222                                    237                 213                 231                 234                 
  **      **Person-years                                                  149546                                 145599              141188              138588              129897              
  **      **Age-adjusted                                                  1 (referent)                           1.05 (0.87, 1.26)   0.94 (0.78, 1.13)   1.02 (0.85, 1.22)   1.06 (0.87, 1.27)   0.65
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.00 (0.83, 1.21)   0.89 (0.73, 1.07)   0.97 (0.80, 1.17)   1.04 (0.86, 1.26)   0.66
  **    Pooled**[^**†**^](#t003fn002){ref-type="table-fn"}                                                                                                                                       
  **      **Age-adjusted                                                  1 (referent)                           1.26 (0.88, 1.79)   1.10 (0.81, 1.50)   1.14 (0.91, 1.43)   1.16 (0.95, 1.41)   0.31
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.21 (0.84, 1.73)   1.04 (0.76, 1.43)   1.09 (0.86, 1.38)   1.14 (0.95, 1.36)   0.41
  **Melanoma**                                                                                                                                                                                   
  **    NHS**                                                                                                                                                                                    
  **      **No. of cases                                                  113                                    151                 169                 184                 122                 
  **      **Person-years                                                  254140                                 265923              266738              260503              240729              
  **      **Age-adjusted                                                  1 (referent)                           1.27 (0.99, 1.61)   1.40 (1.11, 1.78)   1.56 (1.23, 1.97)   1.13 (0.87, 1.46)   0.25
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.18 (0.93, 1.51)   1.29 (1.01, 1.64)   1.43 (1.12, 1.81)   1.05 (0.81, 1.36)   0.56
  **    HPFS**                                                                                                                                                                                   
  **      **No. of cases                                                  105                                    125                 115                 122                 114                 
  **      **Person-years                                                  149652                                 145686              141264              138675              129987              
  **      **Age-adjusted                                                  1 (referent)                           1.19 (0.92, 1.55)   1.13 (0.87, 1.48)   1.22 (0.94, 1.58)   1.18 (0.90, 1.54)   0.29
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.14 (0.87, 1.47)   1.04 (0.80, 1.36)   1.10 (0.84, 1.43)   1.08 (0.82, 1.41)   0.76
  **    Pooled**[^**†**^](#t003fn002){ref-type="table-fn"}                                                                                                                                       
  **      **Age-adjusted                                                  1 (referent)                           1.23 (1.03, 1.47)   1.27 (1.03, 1.57)   1.39 (1.09, 1.77)   1.15 (0.96, 1.39)   0.12
  **      **Multivariate-adjusted [\*](#t003fn001){ref-type="table-fn"}   1 (referent)                           1.16 (0.97, 1.39)   1.17 (0.95, 1.43)   1.26 (0.98, 1.62)   1.06 (0.88, 1.28)   0.55

\* Adjusted for family history of melanoma, natural hair color, number of arm moles, sunburn susceptibility as a child/adolescent, number of lifetime blistering sunburns, average time spent in direct sunlight since high school, cumulative UV flux since baseline, body mass index, physical activity, smoking status, intakes of total energy, alcohol, coffee and citrus intake. Among women analyses were additionally adjusted for menopausal status and postmenopausal hormone use.

^**†**^ The multivariate-adjusted hazard ratios from each cohort were pooled using random effects model.

10.1371/journal.pone.0160308.t004

###### Hazard ratios (and 95% confidence intervals) of skin cancer by supplemental vitamin D intake in the Nurses' Health Study (NHS), and Health Professionals Follow-Up Study (HPFS).

![](pone.0160308.t004){#pone.0160308.t004g}

                                                                          Category of supplemental vitamin D intake   P for trend                                                                     
  ----------------------------------------------------------------------- ------------------------------------------- ------------------- ------------------- ------------------- ------------------- ----------
  **Basal cell carcinoma**                                                                                                                                                                            
  **    NHS**                                                                                                                                                                                         
  **    **Median supplemental vitamin D, IU/d                             0                                           57.1                133.3               266.2               400.0               
  **      **No. of cases                                                  3461                                        1879                2046                2916                1505                
  **      **Person-years                                                  473758                                      198597              205885              265126              138215              
  **      **Age-adjusted                                                  1 (referent)                                1.07 (1.00, 1.13)   1.12 (1.05, 1.18)   1.22 (1.16, 1.28)   1.26 (1.19, 1.34)   \<0.0001
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                1.02 (0.96, 1.08)   1.03 (0.97, 1.09)   1.07 (1.02, 1.13)   1.09 (1.03, 1.16)   \<0.001
  **    HPFS**                                                                                                                                                                                        
  **    **Median supplemental vitamin D, IU/d                             0                                           56.0                133.3               251.2               400.0               
  **      **No. of cases                                                  3584                                        1243                1221                1712                1273                
  **      **Person-years                                                  321957                                      91928               79240               116545              87379               
  **      **Age-adjusted                                                  1 (referent)                                1.09 (1.02, 1.17)   1.19 (1.11, 1.27)   1.14 (1.08, 1.21)   1.19 (1.12, 1.27)   \<0.0001
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                1.05 (0.99, 1.13)   1.10 (1.02, 1.17)   1.02 (0.96, 1.08)   1.05 (0.98, 1.12)   0.27
  **    Pooled**[^**†**^](#t004fn002){ref-type="table-fn"}                                                                                                                                            
  **      **Age-adjusted                                                  1 (referent)                                1.08 (1.03, 1.13)   1.15 (1.08, 1.22)   1.18 (1.11, 1.26)   1.23 (1.16, 1.30)   \<0.0001
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                1.03 (0.99, 1.08)   1.06 (0.99, 1.13)   1.05 (0.99, 1.10)   1.07 (1.03, 1.12)   0.03
  **Squamous cell cancer**                                                                                                                                                                            
  **    NHS**                                                                                                                                                                                         
  **      **No. of cases                                                  264                                         238                 232                 319                 139                 
  **      **Person-years                                                  475608                                      199572              206913              266604              138978              
  **      **Age-adjusted                                                  1 (referent)                                1.14 (0.95, 1.38)   1.13 (0.94, 1.36)   1.22 (1.03, 1.45)   1.31 (1.06, 1.61)   0.01
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                1.04 (0.86, 1.26)   0.96 (0.79, 1.16)   0.98 (0.82, 1.17)   1.00 (0.80, 1.23)   0.70
  **    HPFS**                                                                                                                                                                                        
  **      **No. of cases                                                  427                                         160                 165                 235                 150                 
  **      **Person-years                                                  325089                                      92992               80290               117993              88455               
  **      **Age-adjusted                                                  1 (referent)                                0.96 (0.80, 1.16)   1.05 (0.87, 1.26)   1.07 (0.91, 1.26)   1.13 (0.93, 1.36)   0.13
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                0.91 (0.76, 1.10)   0.92 (0.76, 1.11)   0.88 (0.75, 1.04)   0.92 (0.76, 1.11)   0.24
  **    Pooled**[^**†**^](#t004fn002){ref-type="table-fn"}                                                                                                                                            
  **      **Age-adjusted                                                  1 (referent)                                1.05 (0.88, 1.24)   1.09 (0.95, 1.24)   1.14 (1.01, 1.29)   1.20 (1.04, 1.40)   \<0.01
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                0.98 (0.85, 1.11)   0.94 (0.82, 1.07)   0.92 (0.82, 1.04)   0.95 (0.82, 1.09)   0.26
  **Melanoma**                                                                                                                                                                                        
  **    NHS**                                                                                                                                                                                         
  **      **No. of cases                                                  204                                         140                 130                 176                 89                  
  **      **Person-years                                                  475624                                      199644              207017              266724              139024              
  **      **Age-adjusted                                                  1 (referent)                                1.04 (0.83, 1.31)   1.01 (0.80, 1.27)   1.09 (0.88, 1.35)   1.28 (1.00, 1.65)   0.07
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                0.97 (0.77, 1.22)   0.89 (0.70, 1.12)   0.93 (0.74, 1.15)   1.08 (0.83, 1.40)   0.83
  **    HPFS**                                                                                                                                                                                        
  **      **No. of cases                                                  221                                         94                  77                  113                 76                  
  **      **Person-years                                                  325265                                      93044               80356               118100              88498               
  **      **Age-adjusted                                                  1 (referent)                                1.21 (0.94, 1.55)   1.09 (0.83, 1.42)   1.16 (0.92, 1.46)   1.20 (0.92, 1.55)   0.18
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                1.15 (0.89, 1.48)   0.97 (0.74, 1.28)   0.98 (0.77, 1.24)   1.01 (0.78, 1.32)   0.78
  **    Pooled**[^**†**^](#t004fn002){ref-type="table-fn"}                                                                                                                                            
  **      **Age-adjusted                                                  1 (referent)                                1.12 (0.94, 1.32)   1.04 (0.87, 1.24)   1.12 (0.96, 1.31)   1.24 (1.03, 1.49)   0.02
  **      **Multivariate-adjusted [\*](#t004fn001){ref-type="table-fn"}   1 (referent)                                1.05 (0.88, 1.24)   0.93 (0.78, 1.11)   0.95 (0.81, 1.12)   1.04 (0.87, 1.26)   0.97

^\*^ Adjusted for family history of melanoma, natural hair color, number of arm moles, sunburn susceptibility as a child/adolescent, number of lifetime blistering sunburns, average time spent in direct sunlight since high school, cumulative UV flux since baseline, body mass index, physical activity, smoking status, intakes of total energy, alcohol, coffee and citrus intake. Among women analyses were additionally adjusted for menopausal status and postmenopausal hormone use.

^**†**^ The multivariate-adjusted hazard ratios from each cohort were pooled using random effects model.

Stratified analysis according to sun exposure related factors showed similar trends between vitamin D intake and skin cancers ([S1 Table](#pone.0160308.s001){ref-type="supplementary-material"}).

Among the major vitamin D-contributing food items, dietary intakes of total fish, low fat/skim milk, and cereal showed significant positive associations with risk of BCC ([Table 5](#pone.0160308.t005){ref-type="table"}). The pooled multivariable HRs of BCC for top versus bottom quintiles was 1.11 (95% CI: 1.06 to 1.17; *P*~trend~\<0.01) for fish intake, 1.12 (95% CI: 1.06 to 1.17; *P*~trend~\<0.01) for low fat/skimmed milk intake, and 1.13 (95% CI: 1.01 to 1.27; *P*~trend~\<0.01) for breakfast cereal intake, respectively. Neither total dairy food intake nor egg consumption were significantly associated with risk of BCC. Dietary intakes of vitamin D-rich food items were not significantly associated with the risk of SCC or melanoma in a dose-dependent manner ([S2 Table](#pone.0160308.s002){ref-type="supplementary-material"}). Marginal increased risks for melanoma were found with higher intake of total fish (pooled HR for top versus bottom quintiles = 1.17, 95% CI = 0.98 to 1.41; *P*~trend~ = 0.12), white fish (pooled HR = 1.27, 95% CI = 1.05 to 1.54; *P*~trend~ = 0.07) and breakfast cereal (pooled HR = 1.19, 95% CI = 0.98 to 1.45; *P*~trend~ = 0.10).

10.1371/journal.pone.0160308.t005

###### Multivariate-adjusted Hazard ratios[\*](#t005fn001){ref-type="table-fn"} (and 95% confidence intervals) of Basal Cell Carcinoma by intake of vitamin D rich food in the Nurses' Health Study (NHS), and Health Professionals Follow-Up Study (HPFS).

![](pone.0160308.t005){#pone.0160308.t005g}

                                                             Quintile of vitamin D rich food intake   P for trend                                                                     
  ---------------------------------------------------------- ---------------------------------------- ------------------- ------------------- ------------------- ------------------- ------------
  **Total Fish**                                                                                                                                                                      
  **    NHS**                                                1 (referent)                             1.07 (1.01, 1.13)   1.08 (1.02, 1.15)   1.12 (1.05, 1.19)   1.10 (1.03, 1.17)   *\<0*.*01*
  **    HPFS**                                               1 (referent)                             1.03 (0.96, 1.10)   1.02 (0.94, 1.09)   1.07 (0.99, 1.14)   1.14 (1.06, 1.23)   *\<0*.*01*
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             1.05 (1.00, 1.10)   1.06 (0.99, 1.13)   1.10 (1.04, 1.16)   1.12 (1.07, 1.17)   *\<0*.*01*
  **White Fish**                                                                                                                                                                      
  **    NHS**                                                1 (referent)                             1.02 (0.95, 1.08)   1.01 (0.95, 1.07)   1.05 (0.99, 1.11)   1.04 (0.97, 1.11)   0.14
  **    HPFS**                                               1 (referent)                             1.00 (0.94, 1.07)   1.10 (1.01, 1.20)   1.05 (0.98, 1.12)   1.07 (1.00, 1.15)   0.07
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             1.01 (0.96, 1.06)   1.04 (0.97, 1.11)   1.05 (1.00, 1.09)   1.05 (1.00, 1.10)   *\<0*.*01*
  **Tuna**                                                                                                                                                                            
  **    NHS**                                                1 (referent)                             1.03 (0.97, 1.09)   1.08 (1.02, 1.14)   1.08 (1.02, 1.14)   1.08 (1.01, 1.14)   *0*.*01*
  **    HPFS**                                               1 (referent)                             0.99 (0.92, 1.05)   1.03 (0.95, 1.12)   1.08 (1.00, 1.15)   1.12 (1.04, 1.19)   *\<0*.*01*
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             1.01 (0.96, 1.06)   1.06 (1.02, 1.12)   1.08 (1.03, 1.13)   1.09 (1.05, 1.14)   *\<0*.*01*
  **Total Dairy Food**                                                                                                                                                                
  **    NHS**                                                1 (referent)                             0.99 (0.93, 1.05)   1.01 (0.95, 1.08)   1.01 (0.94, 1.07)   1.04 (0.97, 1.11)   0.27
  **    HPFS**                                               1 (referent)                             1.04 (0.97, 1.11)   1.05 (0.98, 1.13)   1.02 (0.95, 1.10)   1.01 (0.93, 1.09)   0.97
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             1.01 (0.96, 1.06)   1.03 (0.99, 1.08)   1.01 (0.97, 1.06)   1.02 (0.97, 1.08)   *0*.*41*
  **Total Milk**                                                                                                                                                                      
  **    NHS**                                                1 (referent)                             1.06 (1.00, 1.12)   1.07 (1.00, 1.13)   1.07 (1.01, 1.14)   1.09 (1.02, 1.16)   0.02
  **    HPFS**                                               1 (referent)                             1.06 (0.99, 1.14)   1.04 (0.98, 1.11)   1.10 (1.03, 1.18)   1.00 (0.93, 1.07)   0.58
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             1.06 (1.01, 1.11)   1.05 (1.01, 1.10)   1.08 (1.04, 1.13)   1.04 (0.96, 1.13)   *0*.*14*
  **Skim or low fat Milk**                                                                                                                                                            
  **    NHS**                                                1 (referent)                             1.11 (1.04, 1.18)   1.11 (1.04, 1.18)   1.11 (1.04, 1.18)   1.14 (1.07, 1.22)   \<0.01
  **    HPFS**                                               1 (referent)                             1.16 (1.08, 1.24)   1.11 (1.03, 1.19)   1.16 (1.08, 1.24)   1.09 (1.01, 1.17)   0.06
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             1.13 (1.08, 1.19)   1.11 (1.06, 1.16)   1.13 (1.08, 1.18)   1.12 (1.06, 1.17)   *\<0*.*01*
  **Breakfast Cereal**                                                                                                                                                                
  **    NHS**                                                1 (referent)                             1.01 (0.95, 1.07)   1.01 (0.94, 1.07)   1.09 (1.03, 1.16)   1.07 (1.01, 1.14)   *\<0*.*01*
  **    HPFS**                                               1 (referent)                             1.03 (0.96, 1.11)   1.11 (1.04, 1.19)   1.16 (1.08, 1.25)   1.20 (1.12, 1.29)   *\<0*.*01*
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             1.02 (0.97, 1.07)   1.06 (0.96, 1.17)   1.12 (1.06, 1.19)   1.13 (1.01, 1.27)   *\<0*.*01*
  **Egg**                                                                                                                                                                             
  **    NHS**                                                1 (referent)                             0.98 (0.93, 1.04)   1.01 (0.95, 1.07)   0.98 (0.93, 1.04)   0.95 (0.88, 1.02)   0.15
  **    HPFS**                                               1 (referent)                             0.96 (0.89, 1.02)   1.03 (0.96, 1.10)   1.02 (0.96, 1.09)   0.97 (0.89, 1.05)   0.66
  **    Pooled**[^**†**^](#t005fn002){ref-type="table-fn"}   1 (referent)                             0.97 (0.93, 1.01)   1.02 (0.98, 1.06)   1.00 (0.96, 1.04)   0.96 (0.91, 1.01)   *0*.*60*

^\*^ Adjusted for family history of melanoma, natural hair color, number of arm moles, sunburn susceptibility as a child/adolescent, number of lifetime blistering sunburns, average time spent in direct sunlight since high school, cumulative UV flux since baseline, body mass index, physical activity, smoking status, intakes of total energy, alcohol, coffee and citrus intake. Among women analyses were additionally adjusted for menopausal status and postmenopausal hormone use.

^**†**^ The multivariate-adjusted hazard ratios from each cohort were pooled using random effects model.

Discussion {#sec009}
==========

In these large population-based cohort studies, we found that orally taken vitamin D did not exert any protective effect against skin cancer development. Higher intakes of vitamin D from food and from supplements were associated with increased risk of BCC of the skin, while a non-significant increased risk was found with SCC and melanoma. These trends remained despite strategies to minimize confounding by sun exposure. When we examined individual vitamin D-rich foods, intakes of fish, cereal and skim milk were significantly associated with risk of BCC in both cohorts.

Most previous studies on vitamin D and risk of skin cancer used a single measurement of plasma 25(OH)D as a marker of vitamin D level. \[[@pone.0160308.ref009], [@pone.0160308.ref014], [@pone.0160308.ref016], [@pone.0160308.ref017], [@pone.0160308.ref033]\] In a recent meta-analysis, the summary relative risks for the association of highest versus lowest quintile of serum vitamin D levels was 1.64 (95% CI 1.02--2.65) for KC and 1.46 (95% CI 0.60--3.53) for melanoma.\[[@pone.0160308.ref014]\] However, one-time measurement of plasma vitamin D levels is known to mainly reflect sun exposure,\[[@pone.0160308.ref018]\] and may not reflect longer-term vitamin D status. Also, many of the studies in the meta-analysis lacked adjustment for sun exposure related factors and pigmentary traits. Thus, the positive association might be confounded by these factors, especially sun exposure related factors. While sun exposure is a known risk factor for skin cancer development, a potential protective effect of orally taken vitamin D against skin cancer development has been raised based on the evidence from experimental studies. Several animal studies have demonstrated that vitamin D treatment decreases cell growth and metastasis of skin cancer.\[[@pone.0160308.ref034], [@pone.0160308.ref035]\] Other studies have suggested that vitamin D may protect the skin against ultraviolet radiation--induced DNA damage.\[[@pone.0160308.ref007], [@pone.0160308.ref008]\]\[[@pone.0160308.ref036]\] However, in our study, orally taken vitamin D from diet and supplements did not appear to exert any protective effect against KC or melanoma development. Vitamin D intake was rather positively associated with BCC risk. A meta-analysis of cohort/case-control studies and a randomized clinical trial of vitamin D intake and risks of melanoma and KC (largely BCC) found null associations of vitamin D intake with skin cancer.\[[@pone.0160308.ref014]\] The meta-analysis included 5 studies of melanoma and 4 studies of BCC and KC (without separate evaluation of BCC and SCC). The study included earlier follow-up of NHS and HPFS.\[[@pone.0160308.ref011], [@pone.0160308.ref012]\] The sample size of our study was much larger than the meta-analysis, especially for BCC. Thus, we had a better statistical power to detect an association. Furthermore, to our knowledge, our study was the first evaluating vitamin D intake in relation to SCC risk.

Our findings suggest that even intake of vitamin D from diet and/or supplements may be associated with increased risk of BCC. Earlier studies from our group that examined the association of risk of BCC and intakes of multiple nutrients in the NHS (4-years of follow-up)\[[@pone.0160308.ref011]\] and HPFS (8-years of follow-up)\[[@pone.0160308.ref012]\] did not find any significant association for intakes of vitamin D. However, the number of cases was much smaller in the previous investigations (female 771 cases; male 3190 cases) than the present updated analysis. A previous clinical trial did not find a protective effect of calcium/vitamin D supplements on risk of skin cancer either. In the Women\'s Health Initiative calcium/vitamin D clinical trial, daily supplementation with 1,000 mg of calcium and 400 IU of vitamin D for a mean follow-up period of 7.0 years had no effect on KC incidence.\[[@pone.0160308.ref037]\] Also, since the study evaluated calcium and vitamin D together at one dose, it was unknown whether vitamin D per se or vitamin D at different doses would be effective.

The discrepancy between our results and experimental data in animals might be hard to interpret. Besides orally consumed vitamin D, large amount of vitamin D would be synthesized by sunlight exposure.\[[@pone.0160308.ref019]\] However, because sunlight exposure also elevates the risk of skin cancer,\[[@pone.0160308.ref020]--[@pone.0160308.ref022]\] the beneficial effect of vitamin D might be canceled out. Based on our data, it appears that orally taken vitamin D per se is not associated with a reduced risk of skin cancer. In animal models of cutaneous carcinogenesis, high-dose vitamin D treatment in short time periods prior to irradiation with UV was used,\[[@pone.0160308.ref007]\] \[[@pone.0160308.ref036]\] while orally taken vitamin D in the epidemiologic studies may represent chronic low-dose exposure. These differences in the timing and the dose of the exposure may lead to different effects on skin cancer development, but little is known about these associations and further research will be needed.

Although we found a modest positive association between vitamin D intake and BCC risk, the major differences in BCC risk were largely found in lower vitamin D intake quintiles, while the risks were similar among higher quintiles of vitamin D intake. Therefore, the positive association was largely driven by the effect of low vitamin D intake. We cannot exclude the possibility of reporting bias and misclassification of BCC, because the identification of BCC cases in this study was based on self-report. Although previous studied have shown a high accuracy of self-reported BCC (high sensitivity of self-reporting) \[[@pone.0160308.ref012], [@pone.0160308.ref028]\] it is unclear whether self-reporting is highly specific as well. Our participants in the highest quintile of vitamin D intake were less likely to smoke and drink alcohol, which seemed that they were more health-conscious. It is possible that those in the highest quintile of vitamin D intake might be more likely to get skin examination and diagnosis of BCC, which could lead to a HR biased towards positive values. In addition, participants in the highest quintile of vitamin D intake were most likely to be physically active, which could be associated with getting more sun exposure.

On the other hand, other components in vitamin D-rich foods may be responsible for the positive association between vitamin D intake and BCC. Among vitamin D-rich food items, dietary consumptions of fish and cereal were significantly associated with risk of BCC in both cohorts. In the United States, fish and breakfast cereals including rice are important dietary sources of arsenic,\[[@pone.0160308.ref038], [@pone.0160308.ref039]\] which is a possible environmental risk factor of skin cancer by causing oxidative stress, impairing immune function and increasing genotoxicity.\[[@pone.0160308.ref040], [@pone.0160308.ref041]\] A cohort study in Europe suggested that workplace co-exposure to arsenic and sunlight might be associated with an increased risk of KC.\[[@pone.0160308.ref042]\] Another case-control study also showed a positive association between BCC and arsenic exposure in drinking water.\[[@pone.0160308.ref043]\] However, there are few epidemiologic studies to assess the association between dietary arsenic exposure and skin cancer. We also found that intake of low fat/skim milk was associated with increased risk of BCC, while total dairy intake did not show any association. These findings disagree with a previous study that showed a positive association between consumption of unmodified dairy foods with high fat and KC risk.\[[@pone.0160308.ref044]\] Although higher milk intake has been associated with risk of cancer of several organs including liver \[[@pone.0160308.ref045]\], ovary\[[@pone.0160308.ref046]\] and prostate\[[@pone.0160308.ref047]\], little is known about the underlying mechanism of the potential milk-KC association. Further studies are needed to replicate this association in other populations and to explore the underlying mechanisms.

Our study had several limitations. First, our study population consisted of whites, well-educated health professionals, which may limit the generalizability of our results. Second, although we controlled for several strong predictors of skin cancer risk including the cumulative UV flux at residence, average time spent in direct sunlight since high school, number of moles on arms, skin reaction to sun exposure, and number of blistering sunburns, we cannot exclude residual confounding by sun-exposure, which is the primary risk factor for KC and melanoma and difficult to measure accurately. Third, the case numbers of SCC and melanoma were not as high as that of BCC, and we could not exclude the possibility of limited statistical power for those cancers.

In conclusion, we found no evidence that orally taken vitamin D plays an important protective role against the incidence of KC and cutaneous melanoma. Vitamin D intake was significantly and positively associated with risk of BCC. Further research is warranted to confirm our findings and identify the potential mechanisms underlying these associations.
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